W. Joost Lesterhuis School of Biomedical Sciences University of Western Australia Biography Publications Institution JoVE Articles W. Joost Lesterhuis has not added a biography. If you are W. Joost Lesterhuis and would like to personalize this page please email our Author Liaison for assistance. Publications Bilateral Murine Tumor Models for Characterizing the Response to Immune Checkpoint Blockade Nature Protocols. 05, 2020 | Pubmed ID: 32238953 Sensitizing the Tumor Microenvironment to Immune Checkpoint Therapy Frontiers in Immunology. 2020 | Pubmed ID: 32133005 Autologous Monocyte-derived DC Vaccination Combined with Cisplatin in Stage III and IV Melanoma Patients: a Prospective, Randomized Phase 2 Trial Cancer Immunology, Immunotherapy : CII. Mar, 2020 | Pubmed ID: 31980913 Dexamethasone Differentially Depletes Tumour and Peripheral Blood Lymphocytes and Can Impact the Efficacy of Chemotherapy/checkpoint Blockade Combination Treatment Oncoimmunology. 2019 | Pubmed ID: 31646089 Sensitization to Immune Checkpoint Blockade Through Activation of a STAT1/NK Axis in the Tumor Microenvironment Science Translational Medicine. 07, 2019 | Pubmed ID: 31316010 A Systematic Investigation of the Maximum Tolerated Dose of Cytotoxic Chemotherapy with and Without Supportive Care in Mice BMC Cancer. Oct, 2017 | Pubmed ID: 29037232 Transient Treg Depletion Enhances Therapeutic Anti-cancer Vaccination Immunity, Inflammation and Disease. 03, 2017 | Pubmed ID: 28250921 Dynamic Versus Static Biomarkers in Cancer Immune Checkpoint Blockade: Unravelling Complexity Nature Reviews. Drug Discovery. Apr, 2017 | Pubmed ID: 28057932 Chemotherapy and Immunotherapy: Mapping the Road Ahead Current Opinion in Immunology. Apr, 2016 | Pubmed ID: 26724433 Network Analysis of Immunotherapy-induced Regressing Tumours Identifies Novel Synergistic Drug Combinations Scientific Reports. Jul, 2015 | Pubmed ID: 26193793 Neoadjuvant Anti-tumor Vaccination Prior to Surgery Enhances Survival Journal of Translational Medicine. Sep, 2014 | Pubmed ID: 25186961 Molecular Pathways: the Immunogenic Effects of Platinum-based Chemotherapeutics Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Jun, 2014 | Pubmed ID: 24879823 Comment on "drug Discovery: Turning the Titanic" Science Translational Medicine. Mar, 2014 | Pubmed ID: 24670682 Synergistic Effect of CTLA-4 Blockade and Cancer Chemotherapy in the Induction of Anti-tumor Immunity PloS One. 2013 | Pubmed ID: 23626745 Programmed Death Ligand 2 in Cancer-induced Immune Suppression Clinical & Developmental Immunology. 2012 | Pubmed ID: 22611421 A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing (Neo)adjuvant Therapies Francois X. Rwandamuriye1,2, Breana J. Weston2,3, Terrance G. Johns2, W. Joost Lesterhuis1,2, Rachael M. Zemek2 1School of Biomedical Sciences, University of Western Australia, 2Telethon Kids Institute, University of Western Australia, 3College of Science, Health, Engineering and Education, Murdoch University JoVE 60882 Medicine
A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing (Neo)adjuvant Therapies Francois X. Rwandamuriye1,2, Breana J. Weston2,3, Terrance G. Johns2, W. Joost Lesterhuis1,2, Rachael M. Zemek2 1School of Biomedical Sciences, University of Western Australia, 2Telethon Kids Institute, University of Western Australia, 3College of Science, Health, Engineering and Education, Murdoch University JoVE 60882 Medicine
